Samuel Gidding, MD

Samuel Gidding is a clinician–researcher whose work focuses on familial hypercholesterolemia and early‑life cardiovascular risk. At Geisinger, his research emphasizes genomic and implementation science approaches to identifying undiagnosed cases of familial hypercholesterolemia and improving risk stratification. His longstanding interests in atherosclerosis development and hypertension continue through projects aimed at community‑based identification of hypertension, improving blood pressure control, and integrating genomic data into early cardiovascular risk assessment across the lifespan.